A. D. Wist, S. I. Berger, and R. Iyengar, Systems pharmacology and genome medicine: a future perspective, Genome Medicine, vol.1, issue.1, 2009.
DOI : 10.1186/gm11

URL : http://doi.org/10.1186/gm11

C. Hill and F. Doyon, Frequency of cancer in France, Bull Cancer, vol.91, pp.9-14, 2004.

C. Hill, Numéro thématique -Journée mondiale sans tabac, Bulletin Epidémiologique Hebdomadaire, vol.1920, pp.209-224, 2010.

R. Peto, S. Darby, H. Deo, P. Silcocks, E. Whitley et al., Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies, BMJ, vol.321, issue.7257, pp.323-329, 2000.
DOI : 10.1136/bmj.321.7257.323

M. Berdasco and M. Esteller, Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry, Developmental Cell, vol.19, issue.5, pp.698-711, 2010.
DOI : 10.1016/j.devcel.2010.10.005

M. Esteller, Epigenetic gene silencing in cancer: the DNA hypermethylome, Human Molecular Genetics, vol.16, issue.R1, pp.50-59, 2007.
DOI : 10.1093/hmg/ddm018

P. A. Jones and S. B. Baylin, The Epigenomics of Cancer, Cell, vol.128, issue.4, pp.683-692, 2007.
DOI : 10.1016/j.cell.2007.01.029

S. E. Artandi and R. A. Depinho, Telomeres and telomerase in cancer, Carcinogenesis, vol.31, issue.1, pp.9-18, 2010.
DOI : 10.1093/carcin/bgp268

M. G. Farquhar and G. Palade, JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA, The Journal of Cell Biology, vol.17, issue.2, pp.375-412, 1963.
DOI : 10.1083/jcb.17.2.375

M. A. Nieto, The early steps of neural crest development, Mechanisms of Development, vol.105, issue.1-2, pp.27-35, 2001.
DOI : 10.1016/S0925-4773(01)00394-X

J. J. Christiansen and A. K. Rajasekaran, Reassessing Epithelial to Mesenchymal Transition as a Prerequisite for Carcinoma Invasion and Metastasis, Cancer Research, vol.66, issue.17, pp.8319-8326, 2006.
DOI : 10.1158/0008-5472.CAN-06-0410

H. Peinado, M. Quintanilla, and A. Cano, Transforming Growth Factor ??-1 Induces Snail Transcription Factor in Epithelial Cell Lines, Journal of Biological Chemistry, vol.278, issue.23, pp.21113-21123, 2003.
DOI : 10.1074/jbc.M211304200

L. Xie, B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakre et al., Activation of the Erk Pathway Is Required for TGF-??1-Induced EMT In Vitro, Neoplasia, vol.6, issue.5, pp.603-610, 2004.
DOI : 10.1593/neo.04241

Y. Kang and J. Massague, Epithelial-Mesenchymal Transitions, Cell, vol.118, issue.3, pp.277-279, 2004.
DOI : 10.1016/j.cell.2004.07.011

A. Pardee, G1 events and regulation of cell proliferation, Science, vol.246, issue.4930, pp.603-608, 1989.
DOI : 10.1126/science.2683075

C. H. Heldin, Dimerization of cell surface receptors in signal transduction, Cell, vol.80, issue.2, pp.213-223, 1995.
DOI : 10.1016/0092-8674(95)90404-2

D. R. Kaplan, D. K. Morrison, G. Wong, F. Mccormick, W. et al., PDGF ??-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex, Cell, vol.61, issue.1, pp.125-133, 1990.
DOI : 10.1016/0092-8674(90)90220-9

J. Pouyssegur and K. Seuwen, Transmembrane Receptors and Intracellular Pathways that Control Cell Proliferation, Annual Review of Physiology, vol.54, issue.1, pp.195-210, 1992.
DOI : 10.1146/annurev.ph.54.030192.001211

M. Beato, Gene regulation by steroid hormones, Cell, vol.56, issue.3, pp.335-344, 1989.
DOI : 10.1016/0092-8674(89)90237-7

M. A. Carson-jurica, W. T. Schrader, O. Malley, and B. W. , Steroid Receptor Family: Structure and Functions, Endocrine Reviews, vol.11, issue.2, pp.201-220, 1990.
DOI : 10.1210/edrv-11-2-201

D. J. Drucker and P. L. Brubaker, Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine., Proceedings of the National Academy of Sciences, vol.86, issue.11, pp.3953-3957, 1989.
DOI : 10.1073/pnas.86.11.3953

D. Hanahan and R. A. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

W. D. Travis, E. Brambilla, M. Noguchi, A. G. Nicholson, K. Geisinger et al., International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary, Proceedings of the American Thoracic Society, vol.8, issue.5, pp.381-385, 2011.
DOI : 10.1513/pats.201107-042ST

P. A. Janne, A. M. Borras, Y. Kuang, A. M. Rogers, V. A. Joshi et al., A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening, Clinical Cancer Research, vol.12, issue.3, pp.751-758, 2006.
DOI : 10.1158/1078-0432.CCR-05-2047

M. Achille, M. Gallegos-ruiz, G. Giaccone, and J. C. Soria, Response to Erlotinib in First-Line Treatment of Non???Small-Cell Lung Cancer in a White Male Smoker with Squamous-Cell Histology, Clinical Lung Cancer, vol.8, issue.3, pp.214-216, 2006.
DOI : 10.3816/CLC.2006.n.050

D. B. Costa, S. Kobayashi, D. G. Tenen, and M. S. Huberman, Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers, Lung Cancer, vol.58, issue.1, pp.95-103, 2007.
DOI : 10.1016/j.lungcan.2007.05.017

A. A. Adjei, K-ras as a Target for Lung Cancer Therapy, Journal of Thoracic Oncology, vol.3, issue.6, pp.160-163, 2008.
DOI : 10.1097/JTO.0b013e318174dbf9

J. H. Schiller, D. Harrington, C. P. Belani, C. Langer, A. Sandler et al., Comparison of Four Chemotherapy Regimens for Advanced Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.346, issue.2, pp.92-98, 2002.
DOI : 10.1056/NEJMoa011954

F. A. Shepherd, J. Dancey, R. Ramlau, K. Mattson, R. Gralla et al., Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non???Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy, Journal of Clinical Oncology, vol.18, issue.10, pp.2095-2103, 2000.
DOI : 10.1200/JCO.2000.18.10.2095

J. Y. Wu, S. G. Wu, C. H. Yang, C. H. Gow, Y. L. Chang et al., Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response, Clinical Cancer Research, vol.14, issue.15, pp.4877-4882, 2008.
DOI : 10.1158/1078-0432.CCR-07-5123

J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland et al., MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling, Science, vol.316, issue.5827, pp.1039-1043, 2007.
DOI : 10.1126/science.1141478

E. S. Kim, V. Hirsh, T. Mok, M. A. Socinski, R. Gervais et al., Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial, The Lancet, vol.372, issue.9652, pp.1809-1818, 2008.
DOI : 10.1016/S0140-6736(08)61758-4

D. M. Thompson and G. N. Gill, The EGF receptor: structure, regulation and potential role in malignancy, Cancer Surv, vol.4, pp.767-788, 1985.

G. Carpenter and S. Cohen, Epidermal growth factor, J Biol Chem, vol.265, pp.7709-7712, 1990.

Y. Yarden and A. Ullrich, Growth Factor Receptor Tyrosine Kinases, Annual Review of Biochemistry, vol.57, issue.1, pp.443-478, 1988.
DOI : 10.1146/annurev.bi.57.070188.002303

Y. Yarden and M. X. Sliwkowski, Untangling the ErbB signalling network, Nature Reviews Molecular Cell Biology, vol.2, issue.2, pp.127-137, 2001.
DOI : 10.1038/35052073

R. I. Nicholson, J. M. Gee, and M. E. Harper, EGFR and cancer prognosis, European Journal of Cancer, vol.37, issue.4, pp.9-15, 2001.
DOI : 10.1016/S0959-8049(01)00231-3

A. F. Gazdar, Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors, Oncogene, vol.19, issue.1, pp.24-31, 2009.
DOI : 10.1016/j.cell.2006.05.013

R. Rosell, E. Carcereny, R. Gervais, A. Vergnenegre, B. Massuti et al., Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial, and Paz-Ares, L. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, pp.239-246, 2012.
DOI : 10.1016/S1470-2045(11)70393-X

S. Schubbert, K. Shannon, and G. Bollag, Hyperactive Ras in developmental disorders and cancer, Nature Reviews Cancer, vol.91, issue.4, pp.295-308, 2007.
DOI : 10.1038/nrc2109

F. Lerebours, Methods of detection of mutation in human cancers], Bull Cancer, vol.86, pp.877-879, 1999.

N. Chen, L. Tranebjaerg, N. D. Rendtorff, and I. Schrijver, Mutation Analysis of SLC26A4 for Pendred Syndrome and Nonsyndromic Hearing Loss by High-Resolution Melting, The Journal of Molecular Diagnostics, vol.13, issue.4, pp.416-426, 2011.
DOI : 10.1016/j.jmoldx.2011.03.003

D. A. Heideman, F. B. Thunnissen, M. Doeleman, D. Kramer, H. M. Verheul et al., A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes, Cell Oncol, vol.31, pp.329-333, 2009.

M. Beau-faller, H. Blons, C. Domerg, N. Richard, F. Escande et al., A multicenter blinded study evaluating EGFR and KRAS mutation testing methodologies in the clinical non-small cell lung cancer setting -IFCT) platforms, ERMETIC2 project Part 1 -Comparison of testing methods in 20 French Molecular Genetic National Cancer Institute

B. Bennani, S. Gilles, F. Fina, I. Nanni, S. A. Ibrahimi et al., Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer, The International Journal of Biological Markers, vol.25, 2010.
DOI : 10.5301/JBM.2010.6091

P. Tomasini, V. Secq, S. Gilles, I. Rouquette, A. Carlioz et al., Multiplicity and heterogeneity of molecular changes as a potential source of resistance to epidermal growth factor receptor -tyrosine kinase inhibitors (EGFR-TKI) in non-small cell lung cancer, Clin Cancer Res

C. Wittwer, High-resolution DNA melting analysis: advancements and limitations, Human Mutation, vol.64, issue.6, pp.857-859, 2009.
DOI : 10.1002/humu.20951

S. A. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-622, 2009.
DOI : 10.1373/clinchem.2008.112797

J. E. Choi, S. H. Park, K. M. Kim, W. K. Lee, S. Kam et al., Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study, BMC Cancer, vol.110, issue.1, p.199, 2007.
DOI : 10.1007/s00439-001-0656-4

H. Shigematsu and A. Gazdar, Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers, International Journal of Cancer, vol.4, issue.2, pp.257-262, 2006.
DOI : 10.1002/ijc.21496

H. Zhang, X. Zheng, T. Ji, L. Fu, D. Bai et al., Comparative Screening of K-ras Mutations in Colorectal Cancer and Lung Cancer Patients Using a Novel Real-Time PCR with ADx-K-ras Kit and Sanger DNA Sequencing, Cell Biochemistry and Biophysics, vol.12, issue.3, pp.415-420
DOI : 10.1007/s12013-011-9318-x

H. Blons and P. Laurent-puig, Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view], Bull Cancer, vol.96, pp.47-56, 2009.

E. A. Tindall, D. C. Petersen, P. Woodbridge, K. Schipany, H. et al., Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments, Human Mutation, vol.17, issue.6, pp.876-883, 2009.
DOI : 10.1002/humu.20919

B. Vogelstein, K. W. Kinzler, and P. Digital, Digital PCR, Proceedings of the National Academy of Sciences, vol.96, issue.16, pp.9236-9241, 1999.
DOI : 10.1073/pnas.96.16.9236

S. M. Hussein, N. N. Batada, S. Vuoristo, R. W. Ching, R. Autio et al., Copy number variation and selection during reprogramming to pluripotency, Nature, vol.26, issue.7336, pp.58-62, 2011.
DOI : 10.1038/nature09871

T. K. Yung, K. C. Chan, T. S. Mok, J. Tong, K. F. To et al., Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients, Clinical Cancer Research, vol.15, issue.6, pp.2076-2084, 2009.
DOI : 10.1158/1078-0432.CCR-08-2622